Porton Pharma Solutions Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Porton Pharma Solutions: Value creation via innovation & discovery through technical platforms.
One of their notable products is (S)-4-OXO-4,6,7,8-TETRAHYDROPYRROLO[1,2-A]PYRIMIDINE-6-CARBOXYLIC ACID, with a corresponding US DMF Number 41462.
Remarkably, this DMF maintains an Active status since its submission on March 16, 2025, highlighting commitment to regulatory compliance.